This video is the first in a series to remove any doubts regarding the existence of stealth adapted viruses. This is important given the range of neurological illnesses caused by these viruses and the option of energy-based anti-virus therapies. Key Words include chronic fatigue syndrome,
This video is the second in a series intended to remove any doubts regarding the existence of stealth adapted viruses. It describes the first two patients from which stealth adapterd viruses were cultured. One patient was later diagnosed with the chronic fatigue syndrome. The second patient had been diagnosed with bipolar psychosis and had become comatosed. Key Words: encephalopathy, encephalitis, psychiatric illness, chronic fatigue syndrome, CFS, PCR, epilepsy, cytopathic effect, CPE, stealth adapted virus, virus culture, schizophrenia, bipolar psychosis, delusions, hallucinations, fatigue, headaches
This video is the third in a series intended to remove any doubts regarding the existence of stealth adapted viruses. It describes distractions caused by inadvertant linking of my researcsome of the early political and interpersonal h with that of Dr. Elaine DeFreitas. Without precise DNA/RNA sequence data, she had published that most chronic fatigue syndrome patients were infected with a retrovirus related to human T-lymphotropic vius (HTLV) Type II. Financial support for my research was received from the CFIDS Association. Since the CFIDS Assoiciuation was also supporting the work of Dr. DeFreitas, an erroneous assumption was made that I must also be studying a retrovirus, and possibly a Spumavirus. The CFIDS Association support ceased when, in an arranged study, I failed to distinguish patients selected on the basis of fatigue, from control individuals. This was reported in October 1992. Key Words: Chronic Fatigue Syndrome, Virus Encephalopathy, CDC, Stealth Adapted Viruses, PCR, polymerase chain reaction
This video is the fourth in a series intended to remove any doubts regarding the existence of stealth adapted viruses. It describes the generation and sequencing of two polymerase chain reaction (PCR) amplified regions of the atypical virus cultured from a patient with the chronic fatigue syndrome (CFS). One of the virus regions could not be matched with any of the then known DNA sequences in GenBank. The other region, however, showed sequence similarity with a region in human cytomegalovirus. The atypical virus cultured from the CFS patient was clearly distinguishable from human cytomegalovirus. The data were published in the American Journal of Pathology in August 1994.
This video is the fifth in a series intended to remove any doubts regarding the existence of stealth adapted viruses. Cytomegalovirus-related DNA sequence data within the stealth adapted virus are shown to have originated from African green monkey simian cytomegalovirus (SCMV). This finding is relevant to the use of kidney cells from African green monkeys to produce the polio vaccine.
This video is the sixth in a series intended to remove any doubts regarding the existence of stealth adaptred viruses. It reviews aspects of the development of polio vaccines, including the decision to use either formaldehyde treated versus genetically modified (attenuated) polio viruses. The inadvertant use of cytomegalovirus infected monkeys in the production of polio vaccines is discussed. The use of these monkeys has led to the potential introduction into humans of stealth adapted rhesus monkey and African green monkey simian cytomegaloviruses. DNA of these cytomegaloviruses is detectable in polio virus vaccines. Examples are also provided of important safety information regarding polio vaccines being withheld from the public and from the scientific community by Government officials, vaccine manufacturers and researchers. Specific legislation is suggested to compel public disclosure of all safety issues pertaining to vaccines. Humans should be tested for evidence of persisting infections by stealth adapted monkey cytomegaloviruses. The video was produced with support from MI Hope Inc., a public charity